Cancer of the Ovary

2004/12/09 by S A Cannistra · 3 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Ovarian cancer diagnosis and treatment #BRCA gene mutations in cancer #Reproductive Biology and Fertility #Medicine #Ovarian cancer #Disease #Ovary #Cancer #Chemotherapy #Oncology #Gynecology #Internal medicine #Surgery #General surgery #Intensive care medicine

paper · doi:10.1056/nejmra041842

openalex publication_date 2004/12/09 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/04

Abstract

Patients with ovarian cancer usually present with advanced disease, and the disease is generally managed with surgical resection followed by platinum-based chemotherapy. Recent chemotherapeutic advances have led to improved survival, and a better understanding of genetic risk factors has permitted a tailored approach to preventive strategies, such as bilateral salpingo-oophorectomy in selected women. This review describes the clinical features of ovarian cancer and recent advances in postoperative management.

Citations

• A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

Cited by

• A literature review of the social and psychological needs of ovarian cancer survivors
• Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group
• Ovarian cancer [wikipedia]